Education & Programming
The unique format of this year's virtual meeting means you get the great education you've come to rely on ASNC for available when you need it. Create your own personalized educational experience with these sessions.*
Interactive Program Planner Now Available
Cases with the Aces
(Wednesdays in September and October)
Technological Advances and Innovation in Nuclear Cardiology: A Look into the Future, Part 1
PRE 1 Session - Thursday, September 24, 2020 10:00am - 11:00am
Moderators: Mehran Sadeghi, MD; I. George Zubal, PhD
- 10:00AM - Novel SPECT technology - Ling Jian Meng, PhD
- 10:15AM - New PET technology - Joel Karp, PhD
- 10:30AM - Nuclear Imaging in the Interventional Suite - Albert J. Sinusas, MD, FASNC
- 10:45AM - Discussion
Technological Advances and Innovation in Nuclear Cardiology: A Look into the Future, Part 2
PRE 2 Session - Thursday, September 24, 2020 11:10am - 12:10pm
Moderators: Ernest V. Garcia, PhD, MASNC; Piotr J. Slomka, PhD, FASNC
- 11:10AM - Novel Methods for Dynamic Cardiac SPECT Reconstruction - Chi Liu, PhD
- 11:25AM - Low Dose SPECT Reconstruction Methods for Nuclear Cardiology - Michael A. King, PhD
- 11:40AM - Advanced Strategies for PET Cardiac Quantitation - Georges El Fakhri, PhD
- 11:55AM - Discussion
Technological Advances and Innovation in Nuclear Cardiology: A Look into the Future, Part 3
PRE 3 Session - Thursday, September 24, 2020 12:20pm - 1:20pm
Moderators: Simhan Danthi, PhD; Albert J. Sinusas, MD, FASNC
- 12:20PM - Diagnostic Gaps and Related Biology in Contemporary CV Medicine - Mehran Sadeghi, MD
- 12:35PM - Emerging Tracers for CV Molecular Imaging - Peter Caravan, PhD
- 12:50PM - Barriers and Potential Solutions for Clinical Translation of Novel Tracers - Robert J. Gropler, MD, MASNC
- 1:05PM - Discussion
NIH Panel Discussion: Technological Advances and Innovation in Nuclear Cardiology: A Look into the Future
PRE 4 Session - Thursday, September 24, 2020 1:30pm - 2:30pm
Moderators: Andrew E. Arai, MD; I. George Zubal, PhD
- 1:30PM - Big picture! Early Engineering Work; New Technologies; Multi-organ Systems - Jill Heemskerk, PhD
- 1:40PM - Vascular Inflammation, NHLBI, PET/CT & PET/MR and Other Imaging - Nehal Mehta, MD
- 1:50PM - Research PET - Peter Herscovitch, MD
- 2:00PM - PET Probe Development, Chemists - Robert J. Gropler, MD, MASNC
- 2:10PM - Technology Initiatives (Radiotracers, Probes, Camera Development, Reconstruction) - Tatjana Atanasijevic, PhD
- 2:20PM - Discussion
Plenary118 - Mario Verani Lecture and Keynote Presentation
Friday, September 25, 2020 5:00pm - 6:30pm (ET)
- President's Welcome
- ASNC2020 Program Chair Welcome
- Keynote Presentation: Clinical Applications of Artificial Intelligence in Nuclear Cardiology
- Verani Lecture: Evolving Role of Nuclear Cardiology in CAD Management in the Era of Multimodality Imaging
101 - Presidents' Session and Awards Recognition
Friday, September 25, 2020 8:45am - 9:50am (ET)
Special205 - COVID-19: Public Policy Update and Best Practices for Nuclear Cardiology
Saturday, September 26, 2020 10:30am - 11:20am (ET)
- Public Policy Decision Making During the COVID-19 Pandemic
- Best Practices for Nuclear Cardiology During the Pandemic
PET103 - Clinical PET in CAD
Friday, September 25, 2020 10:15am - 11:30am (ET)
- Cardiac PET in the Identification and Characterization of CAD Process and the Arteriolar Vessel
- PET Perfusion and Flow Assessment - Can it Guide Revascularization Strategy in CAD
- Appropriate Use Criteria (AUC) for PET MPI: A Short Overview
- Considerations and Calculations to Establish a Cardiovascular PET Laboratory
111 - Expanding the Clinical Role of Quantitative MBF with PET
Friday, September 25, 2020 2:00pm - 3:30pm (ET)
- Coronary Microvascular Disease: Diagnosis and Patient Management in 2020
- How Can I be Sure that the Reduced MBF Reserve is Meaningful and not Artifactual?
- Can MBF Measurements with PET Replace Invasive Coronary Angiography for Detection of Transplant Vasculopathy?
- Can MBF Reserve Identify Patients with Asymptomatic Aortic Stenosis who Might Benefit from Earlier TAVR?
MOD02 - Clinical Hybrid Imaging
(Meeting on Demand Only)
Clinical Solutions for the Nuclear Cardiologist
(Meeting on Demand Only)
Intersocietal Multimodality Imaging
(Meeting on Demand Only)
Image-based Case Management (Meeting on Demand Only)
Case presentations followed by panel discussion
- MOD03 Integrating CTAC Data in SPECT/CT and PET/CT: Their Complementary Role with CTA
- MOD04 Advanced Imaging in Complex Cases: Added Cost or Added Value
- MOD05 Heart Failure/Chronic CAD
- MOD07 Advanced Imaging in Complex Cases: PET Imaging in Non-ischemic Heart Disease
Overall Goals and ObjectivesIn order to maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2020 is an educational activity designed to help you and other imaging professionals obtain the latest information in clinical practice and review cutting-edge scientific advances in nuclear cardiology and cardiac imaging.
This course is intended for cardiologists, radiologists, nuclear medicine specialists, practice administrators, nuclear technologists, nurses, and other health care professionals with an interest in the field of nuclear cardiology and cardiac CT imaging.
After participating in this activity, learners will be able to:
- Demonstrate improved skills in image interpretation and reporting
- Learn how to recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
- Learn the appropriate use of cardiac imaging techniques based on current guidelines
- Evaluate new imaging technologies, software, and stress techniques
- Understand the role of nuclear and cardiac CT imaging in overall patient care
- Learn the importance of balancing radiation exposure with image quality
- Describe future directions in cardiac PET, CT and SPECT/CT in order to anticipate training and equipment needs
- Understand the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology
- A scientific forum featuring panel discussions on focused areas of cutting-edge research
- State-of-the-art reviews of the key aspects of nuclear cardiology by the world's experts
- A basic core curriculum addressing practical issues in the performance of nuclear cardiology procedures to include opportunities for maintenance of certification credit
- Scientific sessions on advances in nuclear cardiology
- Ethics session will offer case based scenarios dealing with ethical issues
- Educational track dealing with the pathophysiology of multimodality imaging
- Highlight sessions dealing with clinical value of pharmacologic PET
- Presentations addressing technical issues in nuclear cardiology
- Oral abstracts featuring the latest clinical studies in cardiovascular imaging
- Abstracts of original investigation programmed as eposter presentations
- Commercial exhibits displaying the latest in nuclear cardiology technology and services
- Cost-related information in the practice and business of nuclear cardiology
- Opportunities to convene and interact with experts in all aspects of nuclear cardiology and cardiovascular imaging
- The latest information on health policy reform
Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates the live and on demand activity for 55+* AMA PRA Category 1 Credits™and 30* ABIM MOC points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education credit is accepted by both NMTCB and ARRT. ASNC2020 has been approved for a maximum of 30* ARRT Category A Credits for the live sessions only.
Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME.
Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCP) recognizes attendance at CE offerings which provide AMA PRA Category 1 Credits™ for the purpose of recertification.
Maintenance of Certification:
Successful completion of this CME activity enables the participant to earn up to 30* medical knowledge Maintenance of Certification (MOC) points in the American Board of Internal Medicine (ABIM) MOC program. Participants will earn MOC points equivalent to the amount of CME for the live activity only. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
*Credits subject to change. MOC and ARRT available for live sessions only. CME available for live and on demand sessions.
ASNC has received the highest level of recognition, Accreditation with Commendation, from the Accreditation Council for Continuing Medical Education (ACCME). Accreditation with Commendation is awarded to CME providers that demonstrate compliance in all aspects of accreditation requirements and for demonstrating exemplary engagement with the environment in support of physician learning and physician quality improvement.
Statement of NeedRadionuclide-based cardiac imaging studies, including myocardial perfusion imaging (MPI), play an important role in the diagnosis and management of patients with known or suspected heart disease. Today more than 5000 laboratories are performing an estimated 8 million myocardial perfusion studies of which 58% use pharmacological stress agents, either alone with exercise. [DAIC 2013] A large body of scientific evidence exists on the clinical value of MPI, based on studies performed on many thousands of patients. These studies are highly sensitive and specific for the diagnosis, prognosis, and treatment response of coronary artery disease, as well as for selection of patients who may benefit from other types of intervention, including revascularization and device therapy. The value and justification of MPI for risk assessment is based on large observational outcome studies. As a result of the recognized clinical value and cost-effectiveness of these studies, they have been incorporated into many ACC/American Heart Association (AHA)/ASNC clinical management guidelines.
Nuclear cardiology is an evolving field with continuing advances in software, instrumentation and radiopharmaceuticals to provide high quality clinically relevant information for patient care. These advances require those involved in the providing nuclear cardiology studies to be continuously updated to ensure that the procedures are used appropriately and safely and that recent clinical and technological advances are incorporated in a timely manner to continue to improve the image quality and interpretation to provide the best clinical care.
Statement of Need and Learning Gaps